CIBC Private Wealth Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.7K | Buy |
322
+82
| +34% | +$4.51K | ﹤0.01% | 2061 |
|
2025
Q1 | $13.4K | Sell |
240
-356
| -60% | -$19.9K | ﹤0.01% | 2142 |
|
2024
Q4 | $40.8K | Buy |
596
+233
| +64% | +$15.9K | ﹤0.01% | 1755 |
|
2024
Q3 | $25.5K | Hold |
363
| – | – | ﹤0.01% | 2053 |
|
2024
Q2 | $30K | Sell |
363
-185
| -34% | -$15.3K | ﹤0.01% | 1872 |
|
2024
Q1 | $47.7K | Buy |
+548
| New | +$47.7K | ﹤0.01% | 1705 |
|
2023
Q1 | – | Sell |
-9,453
| Closed | -$549K | – | 891 |
|
2022
Q4 | $549K | Sell |
9,453
-47,709
| -83% | -$2.77M | ﹤0.01% | 600 |
|
2022
Q3 | $4.85M | Sell |
57,162
-5,113
| -8% | -$433K | 0.01% | 373 |
|
2022
Q2 | $5.16M | Buy |
62,275
+5
| +0% | +$414 | 0.01% | 370 |
|
2022
Q1 | $4.8M | Hold |
62,270
| – | – | 0.01% | 403 |
|
2021
Q4 | $5.5M | Hold |
62,270
| – | – | 0.01% | 393 |
|
2021
Q3 | $4.81M | Hold |
62,270
| – | – | 0.01% | 397 |
|
2021
Q2 | $5.2M | Buy |
62,270
+169
| +0.3% | +$14.1K | 0.01% | 394 |
|
2021
Q1 | $4.69M | Sell |
62,101
-197
| -0.3% | -$14.9K | 0.01% | 403 |
|
2020
Q4 | $5.46M | Buy |
62,298
+17,798
| +40% | +$1.56M | 0.01% | 377 |
|
2020
Q3 | $3.39M | Buy |
+44,500
| New | +$3.39M | 0.01% | 399 |
|
2020
Q2 | – | Sell |
-28,460
| Closed | -$2.41M | – | 620 |
|
2020
Q1 | $2.41M | Buy |
28,460
+100
| +0.4% | +$8.45K | 0.01% | 383 |
|
2019
Q4 | $2.4M | Buy |
28,360
+4,731
| +20% | +$400K | 0.01% | 445 |
|
2019
Q3 | $1.59M | Buy |
23,629
+19
| +0.1% | +$1.28K | 0.01% | 492 |
|
2019
Q2 | $2.02M | Buy |
23,610
+39
| +0.2% | +$3.34K | 0.01% | 468 |
|
2019
Q1 | $2.09M | Buy |
23,571
+756
| +3% | +$67.2K | 0.01% | 456 |
|
2018
Q4 | $1.94M | Hold |
22,815
| – | – | 0.01% | 454 |
|
2018
Q3 | $2.21M | Buy |
22,815
+5
| +0% | +$485 | 0.01% | 480 |
|
2018
Q2 | $2.15M | Buy |
22,810
+1,470
| +7% | +$138K | 0.01% | 477 |
|
2018
Q1 | $1.73M | Sell |
21,340
-6,533
| -23% | -$530K | 0.01% | 528 |
|
2017
Q4 | $2.49M | Buy |
27,873
+6,413
| +30% | +$572K | 0.01% | 462 |
|
2017
Q3 | $2M | Buy |
+21,460
| New | +$2M | 0.01% | 493 |
|